Karen Kaul to Aged, 80 and over
This is a "connection" page, showing publications Karen Kaul has written about Aged, 80 and over.
Connection Strength
0.255
-
Performance and Utilization of a Laboratory-Developed Nucleic Acid Amplification Test (NAAT) for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in a Low-Prevalence Area. Am J Clin Pathol. 2020 06 08; 154(1):115-123.
Score: 0.088
-
Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma. Leuk Lymphoma. 2007 Mar; 48(3):577-83.
Score: 0.035
-
Clinical Impact of Rapid Point-of-Care PCR Influenza Testing in an Urgent Care Setting: a Single-Center Study. J Clin Microbiol. 2019 03; 57(3).
Score: 0.020
-
A new polymerase chain reaction-based method for the detection of T-cell clonality in patients with possible cutaneous T-cell lymphoma. Arch Dermatol. 1999 Feb; 135(2):158-62.
Score: 0.020
-
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
Score: 0.019
-
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLoS One. 2015; 10(10):e0139049.
Score: 0.016
-
Clinical significance of methicillin-resistant Staphylococcus aureus colonization on hospital admission: one-year infection risk. PLoS One. 2013; 8(11):e79716.
Score: 0.014
-
Dermal hypersensitivity reaction: a PCR-confirmed pattern of herpetic dermatitis. J Cutan Pathol. 2012 Oct; 39(10):929-35.
Score: 0.013
-
Analytical performance determination and clinical validation of the novel Roche RealTime Ready Influenza A/H1N1 Detection Set. J Clin Microbiol. 2010 Sep; 48(9):3088-94.
Score: 0.011
-
The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. Cancer Genet Cytogenet. 2006 Aug; 169(1):33-8.
Score: 0.008
-
High-risk human papillomavirus detection: a split-sample comparison of hybrid capture and chromogenic in situ hybridization. Am J Clin Pathol. 2004 Apr; 121(4):537-45.
Score: 0.007
-
Phase I trial of the diphtheria toxin/interleukin-2 fusion protein DAB486IL-2: efficacy in mycosis fungoides and other non-Hodgkin's lymphomas. Leuk Lymphoma. 1993 Nov; 11(5-6):369-77.
Score: 0.003